The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Commensal Cross-Reactive T & B Cells Trigger Autoimmunity

Commensal Cross-Reactive T & B Cells Trigger Autoimmunity

October 26, 2020 • By Kurt Ullman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Antigens from the microbiota are constantly identified by the immune system, generating a pool of memory T cells and immunoglobulin G (IgG) memory B cells. These immune cells can then cross-react with antigens from the host, which can contribute to the pathogenesis of autoimmune disease. A study in Cell Host & Microbe looks at this interaction in patients with antiphospholipid syndrome (APS).1

You Might Also Like
  • Antibodies to Remicade Cross-React with Biosimilar Remsima
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • Gene Mutation Could Cause Gut Microbe Changes that Lead to RA
Also By This Author
  • Crowdsourcing: The Modern Consult Equivalent

“APS is understudied and undertreated,” says Martin A. Kriegel, MD, PhD, senior author and adjunct professor of immunobiology at Yale School of Medicine, New Haven, Conn. “In APS, the role of the microbiome hasn’t been considered in depth. Given the sheer number of microbes we have, there are quite a few likely to stimulate both T and B cells, which are major drivers of autoimmunity.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Roseburia Intestinalis Exhibits Protein Resembling APS Autoantigen
The researchers searched for a CD4+ Tv cell epitope and the major B cell epitope in the APS autoantigen β2-glycoprotein I (β2GPI) to bacterial proteins in non-redundant protein databases. Candidate sequences were used to identify human commensal gut bacteria with homology to both well-defined autoepitopes. They identified Roseburia intestinalis (R. intestinalis) as a common bacterium that expresses proteins that closely resemble these two epitopes.

Patients with APS who had evidence of immune recognition of R. intestinalis also demonstrated subclinical signs of intestinal inflammation. Human β2GPI-autoreactive lymphocytes and autoantibodies from APS patients cross-reacted with homologous areas expressed by R. intestinalis. Specifically, autoantigen-reactive CD4+ memory T cell clones and an APS-derived monoclonal antibody cross-reacted with epitopes from R. intestinalis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Core-sequence-dependent anti-R. intestinalis IgG titers were significantly elevated in APS patients, and correlated with anti-β2GPI IgG autoantibodies. Additionally, the bacterium was identified as a chronic driver of β2GPI autoreactivity in a murine model, demonstrating T and B cell cross reactivity in vivo with progression in APS-prone mice.

Dr. Kriegel

Cross-Reactive Triggers: A Potential Risk Factor
“One of the interesting things coming out of our research is that a bug that is beneficial in disease A, can be really bad in disease B,” says Dr. Kriegel. “This [finding] is especially true in autoimmune diseases in which the immune system overshoots in different ways depending on the disease. In APS, based on these cross-reactive triggers in R. intestinalis, the presence of R. intestinalis can be a potential risk factor for autoimmune disease, but may have metabolic benefits for gut inflammation. The risk of one autoimmune disease may be related to different aspects of the same bacterium that mitigates another autoimmune disease.”

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: Antiphospholipid Antibody Syndrome (APS), Hughes Syndrome, Microbiome, microbiota

You Might Also Like:
  • Antibodies to Remicade Cross-React with Biosimilar Remsima
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • Gene Mutation Could Cause Gut Microbe Changes that Lead to RA
  • Alterations in the Microbiome Are Associated with Changes in Bone Quality

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)